CD34+ myofibroblasts promote neointima formation in vein grafts by activating ferroptosis-induced smooth muscle cell phenotype switch
Open Access
- 14 October 2026
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
Abstract
Aims: Vein graft (VG) failure due to adverse remodelling and aggressive neointimal hyperplasia is a major complication and key limiting factor for maintaining long-term VG patency. CD34+ cells have been implicated in multiple cardiovascular diseases, but their functional involvements and contributions to VG failure remain elusive. In this study, we aimed to investigate the functional role of CD34+ cells in VG pathogenesis. Methods and result: Single-cell RNA sequencing (scRNA-seq) analysis was conducted to uncover cellular heterogeneity of normal healthy and grafted veins as well as CD34+ cells in VGs. Genetic lineage tracing and depletion strategies were applied to delineate the functional involvements and potential contributions of CD34+ cells to VG remodelling. Multiple functional and biochemistry assays were conducted to identify and elucidate the key signal pathways underpinning smooth muscle cell (SMC) ferroptosis and phenotype switching. A total of 22 513 cells from normal healthy and grafted veins were included in scRNA-seq analysis, which showed a heterogeneous population of CD34+ cells as well as activated ferroptosis pathways and SMC phenotypic alterations in VGs. Using the inducible lineage tracing Cd34-CreERT2;R26-tdTomato mouse model, we showed that CD34+ cells were mainly differentiated into fibroblasts in VGs. Depletion of CD34+/Postn+ myofibroblasts in a triple transgenic (Cd34-Dre;Postn-CreERT2;Dou-tdT-DTR) mouse model significantly decreased VG-induced neointimal hyperplasia. Cellular communication analysis identified Jagged 1/Notch3 (neurogenic locus notch homologue protein 3) as the most upregulated signalling axis between CD34+ cell-derived fibroblasts and SMCs. Notch3 activation in SMCs by CD34+ cell-derived fibroblasts promoted SMC ferroptosis and switching to a synthetic/secretory phenotype in VGs. Blocking Jagged1 and Notch3 signalling as well as inhibition of ferroptosis attenuated vascular adverse remodelling and neointimal hyperplasia in VGs. Conclusion: This study provides a transcriptional and cellular landscape in normal healthy and grafted veins and shows that heterogeneous CD34+ cells serve as a key contributor to vascular remodelling and neointimal hyperplasia in VGs. We also demonstrate that CD34+ cell-derived myofibroblasts promote neointimal hyperplasia through Jagged1/Notch3 signal axis, suggesting that blocking Jagged1/Notch3 activation or inhibiting ferroptosis may provide a novel approach to prevent VG failure.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LQ22H020011)
- British Heart Foundation (FS/17/24/32596)
- British Heart Foundation (PG/15/11/31279)
- British Heart Foundation (PG/15/86/31723)
- British Heart Foundation (PG/20/10458)
- British Heart Foundation (PG/23/11371)
This publication has 55 references indexed in Scilit:
- Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasiaClinical and Translational Medicine, 2024
- The mechanisms of ferroptosis and its role in atherosclerosisBiomedicine & Pharmacotherapy, 2024
- Host CD34+ cells are replacing donor endothelium of transplanted heartThe Journal of Heart and Lung Transplantation, 2023
- Multilineage contribution of CD34+ cells in cardiac remodeling after ischemia/reperfusion injuryBasic Research in Cardiology, 2023
- CD34+ cell atlas of main organs implicates its impact on fibrosisCellular and Molecular Life Sciences, 2022
- Coronary Artery Bypass Surgery Without Saphenous Vein GraftingJACC, 2022
- Notch3 regulates ferroptosis via ROS‐induced lipid peroxidation in NSCLC cellsFEBS Open Bio, 2022
- Single Cell RNA-Seq: Cell Isolation and Data Analysis2021
- Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite graftsThe Journal of Thoracic and Cardiovascular Surgery, 2021
- Fibroblasts: Origins, definitions, and functions in health and diseaseCell, 2021